Mechanisms underlying the effect of polysaccharides in the treatment of type 2 diabetes: A review

Carbohydr Polym. 2016 Jun 25:144:474-94. doi: 10.1016/j.carbpol.2016.02.040. Epub 2016 Feb 18.

Abstract

Type 2 diabetes mellitus, a common metabolic and endocrine disorder worldwide, causes severe health and economic problems. At present, pharmacotherapy involving synthetic diabetic agents is clinically administered for diabetic therapy, which has certain side effects. Fortunately, various natural polysaccharides have anti-diabetic activity and use of these polysaccharides as adjuncts to conventional therapies is increasing in developing countries. A literature search was conducted to obtain relevant information of anti-diabetic polysaccharide from electronic databases, namely PubMed, Web of Science, ScienceDirect, and Springer, for the period 2011-2015. In total, 114 types of polysaccharides from 78 kinds of natural sources, namely plants, fungi, algae, animals, and bacteria, have shown anti-diabetic properties. In vivo and in vitro experiments have shown that administering these polysaccharides has hypoglycaemic effects and alleviates β-cell dysfunction in addtion to eliciting other anti-diabetic activities which are equally efficient to even more efficient than those of synthetic diabetic agents.

Keywords: Anti-diabetic; Beta cell; Diabetes mellitus; Mechanism; Polysaccharides; Type 2 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / enzymology
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetes Mellitus, Type 2 / pathology
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Glucose / metabolism
  • Humans
  • Hypoglycemic Agents / pharmacology*
  • Hypoglycemic Agents / therapeutic use
  • Insulin-Secreting Cells / drug effects
  • Insulin-Secreting Cells / pathology
  • Polysaccharides / pharmacology*
  • Polysaccharides / therapeutic use

Substances

  • Enzyme Inhibitors
  • Hypoglycemic Agents
  • Polysaccharides
  • Glucose